CE Certified Oncology Clinical Trial Wearable Sensor Factories & Exporter serving Finland

Empowering Finnish University Hospitals, CROs, and Biotech Innovators with ISO 13485 & CE MDR Class IIa/IIb Medical Wearables for Continuous Multi-Parameter Bio-Signal Monitoring & Decentralized Clinical Trials (DCT).

CE-MDR Certified FDA 510(k) Cleared ISO 13485 Factory Direct EU GDPR Data Compliance
400B+
Physiological Datapoints
10,000+
Devices Manufactured
200+
Clinical Trials Supported
128 Hz
Raw ECG / PPG Sampling
Medical-Grade Wearable Catalog

CE Certified Sensor Solutions for Oncology & Continuous Monitoring

Precision wrist-worn bio-sensors engineered for real-time cardiotoxicity tracking, vital sign monitoring, and remote clinical trial compliance across Finland and the Nordic region.

ECG + AI Health E500 ECG Screenless AI Health Smart Bracelet
E500 ECG Screenless AI Health IP68 Smart Bracelet Monitor
  • Single-Lead ECG & PPG Array
  • IP68 Submersible Waterproofing
  • Continuous SpO2 & Temperature
OEM / ODM Custom VALDUS VITRO Screenless ECG Health Fitness Tracker
VALDUS VITRO OEM/ODM Screenless ECG Health Tracker Band
  • Zero-Distraction Screenless Design
  • Extended 15-Day Battery Endurance
  • Raw Bio-Signal SDK Access
4G Cellular + GPS V6G 4G Smart Health Bracelet with ECG PPG GPS SOS
V6G 4G Cellular Telemetry Health Bracelet with ECG & SOS
  • Standalone Direct 4G Data Sync
  • Integrated GPS & Fall Detection
  • Real-Time Arrhythmia Alerts
Minimalist Ergonomic Minimalist ECG Magnetic Couple Bracelet Sensor
Minimalist Electrocardiogram Magnetic Bio-Sensor Bracelet
  • Medical Grade Stainless Electrodes
  • Ultra-Lightweight Ergonomic Form
  • High Compliance Trial Design
Multi-Sensor BioBand Screenless Smart Bracelet G70 ECG Temperature
G70 Screenless Clinical Sensor Band for Temp & ECG
  • Continuous Skin Temp Monitoring
  • Multi-Wavelength Optical PPG
  • Automated Sleep & Activity Staging
1ATM Waterproof VITRO Smart Fitness Bracelet Waterproof ECG
VITRO Clinical Multi-Parameter Waterproof Fitness Band
  • High-Precision Heart Rate & ECG
  • iOS & Android Gateway Compatibility
  • Remote Tele-health Monitoring
3ATM / 15-Day Power ECG No Screen Smart Bracelet 180mAh 15 Days Battery
ECG No-Screen Long-Life Smart Bracelet (180mAh)
  • 15 Days Continuous Runtime
  • 3ATM Hydro-Sealed Enclosure
  • SpO2 & Continuous Pedometer
NFC + ECG Bioband 2026 E500 Screenless Smart Bracelet NFC ECG
2026 E500 NFC Screenless Bio-Sensor Trial Bracelet
  • Patient Identification NFC Module
  • Continuous Blood Pressure Trend
  • Clinical Trial Protocol Ready

Decentralized Oncology Clinical Trials (DCT) in Finland: The Wearable Paradigm

Modern oncology drug development is undergoing a rapid structural transition toward Decentralized Clinical Trials (DCT) and hybrid monitoring frameworks. In Finland, where the healthcare ecosystem is anchored by world-class research institutes such as the HUS Comprehensive Cancer Center (Helsinki University Hospital), Tampere University Hospital (TAUH), and Oulu University Hospital (OYS), the integration of continuous, medical-grade bio-sensor wearables has become indispensable. Cancer patients undergoing aggressive chemotherapy, targeted immunotherapy, or novel antibody-drug conjugate (ADC) therapies frequently experience systemic toxicity, transient febrile episodes, and severe fatigue between scheduled hospital visits.

Traditional clinical protocol relies heavily on episodic clinic visits—leaving multi-week observational blind spots. As a specialized OEM/ODM manufacturer and international exporter, our CE-certified wearable sensor platform bridges this monitoring gap. By capturing high-frequency physiological parameters—including single-lead ECG rhythm strips, optical photoplethysmography (PPG at up to 128 Hz), skin surface temperature, galvanic skin response (GSR), and pulse oximetry (SpO2)—our wrist-worn biosensors deliver complete longitudinal visibility into patient health status without imposing patient burden.

Key Benefits for Finnish Trial Sponsors & CROs:

  • Early Detection of Neutropenic Fever: Continuous dermal temperature monitoring detects hyperthermic spikes hours before standard oral thermometry, enabling rapid anti-infective intervention in immunocompromised cancer subjects.
  • Cardiotoxicity & QTc Prolongation Tracking: On-demand and continuous single-lead ECG recording allows biostatisticians to measure QTc interval alterations induced by targeted kinase inhibitors and oncology therapeutics.
  • Objective Performance Status Metrics: Replaces subjective ECOG score surveys with objective 3-axis accelerometer kinetic data, tracking true ambulatory activity and resting circadian sleep fragmentation.
Corsano Medical Wearable Monitoring System Architecture
Enterprise OEM & Export Capabilities

Engineered for Clinical Research Rigor

Our medical wearables are built from the ground up for medical device regulatory compliance, seamless cloud integration, and comfortable long-term wear in extreme environmental conditions.

CE MDR & ISO 13485 Certified

Manufactured under strict ISO 13485 quality systems. Fully compliant with EU Medical Device Regulation (EU-MDR 2017/745) Class IIa/IIb standards, ensuring seamless ethics board approvals across Finland and Europe.

Unrestricted Raw Data Access (128Hz)

No vendor lock-in or proprietary data obfuscation. Researchers receive full IP-free export of raw 128 Hz optical PPG waveforms, micro-volt ECG traces, and accelerometer vectors via REST API or Mobile SDKs.

Nordic Climate Adaptability

Engineered for sub-zero thermal stability down to -20°C. Advanced optical PPG gain adjustment compensating for peripheral vasoconstriction caused by harsh Finnish winter climates.

EU GDPR & HIPAA Compliant Security

End-to-end AES-256 encrypted telemetry transmission with local EU data residency option. Purpose-built for integration with Finland's Kanta health archive and national MyData frameworks.

Screenless Design for Maximum Adherence

Eliminates patient distraction and anxiety by removing interactive screens. Ensures zero accidental touch inputs while extending continuous battery performance up to 15 days on a single magnetic USB charge.

EMR & eCOA System Interoperability

Directly interfaces with Epic Hyperspace, Cerner, and Finnish regional healthcare EHR systems via HL7 FHIR protocols. Seamlessly couples biometric streams with electronic patient-reported outcomes (eCOA).

Adapting Bio-Sensors to Finland’s Wellbeing Services Counties (Hyvinvointialueet)

Finland’s recent structural social and healthcare reform introduced 21 Wellbeing Services Counties (hyvinvointialueet), alongside the City of Helsinki and HUS Group, tasked with streamlining clinical pathways and lowering care delivery costs. In this modernized framework, remote monitoring wearables serve as an essential technological bridge connecting tertiary cancer centers with home-based palliative and active treatment monitoring.

When deploying medical wearables across Finland, factory exporters must satisfy stringent localized criteria. Our production lines provide specialized hardware and firmware customizations explicitly optimized for Nordic requirements:

Kiwa CE Medical Device Certification for Wearable Biosensors

Localized Compliance & Engineering Features:

  1. Biobank & FinnGen Project Compatibility: Data pipelines support integration with Finland's rich biobank network (such as THL Biobank and Finnish Biobank Cooperative - FINBB), allowing combined genomic and continuous physiological data analysis.
  2. Sub-Zero Thermal Micro-Capacitor Design: Custom Li-po battery chemistry prevents rapid passive discharge in extreme sub-zero Finnish winters, guaranteeing stable voltage during outdoor patient movement.
  3. Biocompatible Hypoallergenic Silicones: ISO 10993 cytotoxicity and skin irritation certification, essential for oncological subjects experiencing skin sensitivity due to radiation therapy or epidermal growth factor receptor (EGFR) inhibitors.

Factory Direct B2B OEM/ODM Customization for International Exporters

As a vertically integrated manufacturer, we eliminate intermediary distributor markups, supplying Finnish trial sponsors, MedTech brands, and CRO contract research organizations directly from our ISO 13485 certified production facilities. Whether your project requires custom firmware for specialized arrhythmia detection algorithms, white-labeled mobile SDKs, or branded enclosure packaging, our engineering team provides end-to-end ODM support.

Custom ODM/OEM Services Include:

  • Custom optical LED wavelength pairing (Green 525nm, Red 660nm, Infrared 940nm) for optimized dermal penetration across varied skin phototypes.
  • NFC chip integration for tap-to-pair hospital ward assignment and patient ID verification.
  • Automated early warning score (EWS) algorithm embedding directly into sensor MCU for offline edge computing alerts.
  • Direct supply chain export logistics to Helsinki-Vantaa airport with complete customs compliance documentation under EU free-trade directives.
Raw ECG and PPG Bio-Signal Waveform Analysis
Procurement FAQ

Frequently Asked Questions from Finnish Buyers & Researchers

Essential answers regarding CE MDR compliance, data governance, export logistics, and technical specifications for trial teams in Finland.

1. Are your wearable sensors fully certified under EU Medical Device Regulation (EU-MDR 2017/745) for use in Finnish hospitals?
Yes. Our wearable sensors and monitoring platform carry verified CE-MDR certification issued by accredited EU Notified Bodies (such as Kiwa 1984), as well as ISO 13485 quality management certification. This regulatory backing allows immediate deployment across Finnish public university hospitals (HUS, TAUH, OYS, TYKS, KYS) and private healthcare clinics without requiring experimental device exemptions for standard clinical monitoring.
2. How do your wearable devices support decentralized oncology trials (DCT) in remote regions of Finland?
Our devices utilize screenless, high-compliance designs coupled with low-power Bluetooth 5.2 mesh gateways or 4G cellular telemetry. Patients residing in remote Northern Finland (Lapland) or rural wellbeing counties can wear the lightweight band continuously. Vital signs—including heart rate variability, SpO2, skin temperature, and single-lead ECG—are automatically encrypted and transmitted to the trial portal, eliminating the need for frequent travel to tertiary urban hospitals.
3. Can researchers export raw PPG and ECG data without algorithm lock-in?
Absolute transparency is guaranteed. We provide complete, IP-free access to raw unfiltered 128 Hz multi-spectral PPG (Green, Red, IR), raw single-lead ECG micro-volt readings, 3-axis accelerometer kinetic channels, and skin temperature data via REST APIs, CSV batch exports, or mobile SDKs. Finnish biostatisticians and academic teams can run custom machine learning algorithms and digital biomarker models directly on the raw data.
4. How is Finnish patient data privacy handled in compliance with EU-GDPR and local health regulations?
Data architecture is designed strictly in accordance with EU General Data Protection Regulation (GDPR) Article 9 regarding special categories of health data. All telemetry is encrypted in transit (TLS 1.3) and at rest (AES-256). We support local EU server hosting (e.g., AWS Frankfurt/Stockholm or local Finnish cloud infrastructure), ensuring patient data never leaves the European Economic Area (EEA).
5. How do the sensors perform in sub-zero Finnish outdoor conditions during winter?
Our enclosures are IP68/3ATM water and dust sealed with industrial grade thermistors and cold-resilient lithium-polymer battery cells tested down to -20°C. Furthermore, optical PPG sensors feature automatic transimpedance amplifier gain adjustment to maintain reliable pulse wave capture even when low ambient temperatures cause peripheral skin vasoconstriction.
6. What is the typical lead time and minimum order quantity (MOQ) for factory direct export to Finland?
For evaluation samples and clinical pilot trials (5 to 50 units), shipping from stock to Finland takes 3–5 business days via DHL/FedEx Express. For bulk B2B OEM orders or custom ODM software/hardware adaptations, standard production lead times are 3–5 weeks, with flexible MOQs tailored to academic clinical trial budgets.

Request a Clinical Wearable Evaluation Kit for Your Trial

Consult with our biomedical engineering team to review full technical datasheets, raw signal SDK documentation, and CE MDR compliance certificates for your oncology trial or hospital project in Finland.